Literature DB >> 23778803

CIS: the late-blooming eldest son.

Akihiko Yoshimura1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23778803     DOI: 10.1038/ni.2645

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

Review 1.  Suppressors of cytokine signaling and immunity.

Authors:  Masato Kubo; Toshikatsu Hanada; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-12       Impact factor: 25.606

2.  CISH is induced during DC development and regulates DC-mediated CTL activation.

Authors:  Mohammad Alam Miah; Cheol-Hee Yoon; Joonoh Kim; Jinah Jang; Young-Rim Seong; Yong-Soo Bae
Journal:  Eur J Immunol       Date:  2011-12-12       Impact factor: 5.532

Review 3.  Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.

Authors:  Taiga Tamiya; Ikko Kashiwagi; Reiko Takahashi; Hideo Yasukawa; Akihiko Yoshimura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05       Impact factor: 8.311

4.  Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity.

Authors:  Jeffrey J Babon; Nadia J Kershaw; James M Murphy; Leila N Varghese; Artem Laktyushin; Samuel N Young; Isabelle S Lucet; Raymond S Norton; Nicos A Nicola
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

Review 5.  Th9 cells: differentiation and disease.

Authors:  Mark H Kaplan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

6.  The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.

Authors:  Xuexian O Yang; Huiyuan Zhang; Byung-Seok Kim; Xiaoyin Niu; Juan Peng; Yuhong Chen; Romica Kerketta; Young-Hee Lee; Seon Hee Chang; David B Corry; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  Nat Immunol       Date:  2013-06-02       Impact factor: 25.606

Review 7.  SOCS proteins, cytokine signalling and immune regulation.

Authors:  Akihiko Yoshimura; Tetsuji Naka; Masato Kubo
Journal:  Nat Rev Immunol       Date:  2007-05-18       Impact factor: 53.106

8.  CISH and susceptibility to infectious diseases.

Authors:  Chiea C Khor; Fredrik O Vannberg; Stephen J Chapman; Haiyan Guo; Sunny H Wong; Andrew J Walley; Damjan Vukcevic; Anna Rautanen; Tara C Mills; Kwok-Chiu Chang; Kai-Man Kam; Amelia C Crampin; Bagrey Ngwira; Chi-Chiu Leung; Cheuk-Ming Tam; Chiu-Yeung Chan; Joseph J Y Sung; Wing-Wai Yew; Kai-Yee Toh; Stacey K H Tay; Dominic Kwiatkowski; Christian Lienhardt; Tran-Tinh Hien; Nicholas P Day; Nobert Peshu; Kevin Marsh; Kathryn Maitland; J Anthony Scott; Thomas N Williams; James A Berkley; Sian Floyd; Nelson L S Tang; Paul E M Fine; Denise L M Goh; Adrian V S Hill
Journal:  N Engl J Med       Date:  2010-05-19       Impact factor: 91.245

9.  Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells.

Authors:  S Li; S Chen; X Xu; A Sundstedt; K M Paulsson; P Anderson; S Karlsson; H O Sjögren; P Wang
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

10.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  1 in total

1.  Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

Authors:  Douglas C Palmer; Geoffrey C Guittard; Zulmarie Franco; Joseph G Crompton; Robert L Eil; Shashank J Patel; Yun Ji; Nicholas Van Panhuys; Christopher A Klebanoff; Madhusudhanan Sukumar; David Clever; Anna Chichura; Rahul Roychoudhuri; Rajat Varma; Ena Wang; Luca Gattinoni; Francesco M Marincola; Lakshmi Balagopalan; Lawrence E Samelson; Nicholas P Restifo
Journal:  J Exp Med       Date:  2015-11-02       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.